Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 opportunities
4.4 constraints
Chapter 5 Market Segmentation by Type
5.1 Neurology Devices
5.1.1 By Type of Device
5.1.1.1 Neurosurgery Devices
5.1.1.1.1 Neuroendoscopes
5.1.1.1.2 Stereotactic Systems
5.1.1.1.3 Aneurysm Clips
5.1.1.1.4 Ultrasonic Aspirators
5.1.1.2 Interventional Neurology Devices
5.1.1.2.1 Neurothrombectomy Devices
- Clot Retrievers
- Suction Aspiration Devices
- Snare Devices
5.1.1.2.2 Cerebral Balloon Devices
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
5.1.1.2.3 Aneurysm Coiling & Embolization
- Embolic Coils
- Liquid Embolic Agents
- Flow Diversion Devices
5.1.1.2.4 Support Devices
5.1.1.3.4 Neurostimulation Devices
5.1.1.3.1 Spinal Cord Stimulation Devices
5.1.1.3.2 Deep Brain Stimulation Devices
5.1.1.3.3 Sacral Nerve Stimulation Devices
5.1.1.3.4 Vagus Nerve Stimulation Devices
5.1.1.3.5 Gastric Electric Stimulation Device
5.1.4.1 Cerebrospinal Fluid Management Devices
5.1.1.1.1 Cerebral Shunts
5.1.1.1.2 Cerebral External Drainage
Chapter 6 Market Segmentation by Geography
6.1 UK
Chapter 7 Competitive Landscape
7.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
7.2 Market Share Analysis
7.3 Strategies Adopted By Top Companies
Chapter 8 Company Profiles
8.1 Adaptimmune Therapeutics
8.1.1 Company Overview
8.1.2 Business Segments
8.1.3 Financial Performance ( Public Enterprises)
8.1.4 SWOT Analysis
8.2 Chroma Therapeutics
8.3 Immunocore
8.4 PsiOxus Therapeutics
8.5 Summit Therapeutics
8.6Acumed
8.7Glaxo SmithKline
8.8Recipharm
8.9ProMetic Life Sciences
8.10Teleflex Medical
8.11The binding site
8.12Cambridge Research Biochemicals
8.13Biofortuna
8.14DiscoveRx
8.15Parexel
Chapter 9 Market Insights
9.1 Insights of Industry Experts
9.2 Analyst Opinion (Market Understanding)
9.3 Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
